DK0966283T3 - Farmaceutiske præparater til helbredelse og forebyggelse af sygdomme, som stammer fra beskadigelse af vaskulære endotelceller - Google Patents

Farmaceutiske præparater til helbredelse og forebyggelse af sygdomme, som stammer fra beskadigelse af vaskulære endotelceller

Info

Publication number
DK0966283T3
DK0966283T3 DK97933813T DK97933813T DK0966283T3 DK 0966283 T3 DK0966283 T3 DK 0966283T3 DK 97933813 T DK97933813 T DK 97933813T DK 97933813 T DK97933813 T DK 97933813T DK 0966283 T3 DK0966283 T3 DK 0966283T3
Authority
DK
Denmark
Prior art keywords
pct
endothelial cells
pharmaceuticals
healing
prevention
Prior art date
Application number
DK97933813T
Other languages
Danish (da)
English (en)
Inventor
Laszlo Ueroegdi
Mihaly Barabas
Istvan Kurucz
Laszlo Koranyi
Sandor Erdoe
Marta Vitai
Marta Sinka
Andrea Jednakovits
Ede Marvanyos
Ernoe Bacsy
Gyoergy Dorman
Magdolna Toeroek
Gyoergy Schmidt
Original Assignee
Cytrx Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from HU9602204A external-priority patent/HUP9602204D0/hu
Priority claimed from HU9701349A external-priority patent/HUP9701349A1/hu
Application filed by Cytrx Corp filed Critical Cytrx Corp
Application granted granted Critical
Publication of DK0966283T3 publication Critical patent/DK0966283T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/15—Oximes (>C=N—O—); Hydrazines (>N—N<); Hydrazones (>N—N=) ; Imines (C—N=C)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4453—Non condensed piperidines, e.g. piperocaine only substituted in position 1, e.g. propipocaine, diperodon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
DK97933813T 1996-08-09 1997-08-06 Farmaceutiske præparater til helbredelse og forebyggelse af sygdomme, som stammer fra beskadigelse af vaskulære endotelceller DK0966283T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU9602204A HUP9602204D0 (en) 1996-08-09 1996-08-09 Pharmaceutical compositions for treating diseases connected with the disfunction of the vascular endothelial cells
HU9701349A HUP9701349A1 (hu) 1997-08-04 1997-08-04 Gyógyászati készítmények a vaszkuláris endoteliális sejtek rendellenes működésével összefüggő betegségek gyógyítására vagy megelőzésére

Publications (1)

Publication Number Publication Date
DK0966283T3 true DK0966283T3 (da) 2006-10-09

Family

ID=90014231

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97933813T DK0966283T3 (da) 1996-08-09 1997-08-06 Farmaceutiske præparater til helbredelse og forebyggelse af sygdomme, som stammer fra beskadigelse af vaskulære endotelceller

Country Status (20)

Country Link
US (1) US6143741A (bg)
EP (1) EP0966283B1 (bg)
JP (1) JP2001504446A (bg)
AT (1) ATE329592T1 (bg)
AU (1) AU739614B2 (bg)
BG (1) BG64456B1 (bg)
CA (1) CA2262997C (bg)
CZ (1) CZ298542B6 (bg)
DE (1) DE69736130T2 (bg)
DK (1) DK0966283T3 (bg)
EE (1) EE04044B1 (bg)
ES (1) ES2267148T3 (bg)
HK (1) HK1025506A1 (bg)
IL (1) IL128256A (bg)
NO (1) NO325109B1 (bg)
PT (1) PT966283E (bg)
RS (1) RS49719B (bg)
SK (1) SK284301B6 (bg)
UA (1) UA64716C2 (bg)
WO (1) WO1998006400A2 (bg)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU9701081D0 (en) 1997-06-23 1997-08-28 Gene Research Lab Inc N Pharmaceutical composition of antitumoral activity
HU226617B1 (en) * 1998-12-14 2009-04-28 Cytrx Corp Optically active pyridyl-4h-1,2,4-oxadiazine derivatives, and pharmaceutical composition containing the compound as active ingredient
HUP9900475D0 (en) * 1999-02-26 1999-04-28 Biorex Kutato Fejlesztoe Kft O-(3-piperidino-2-hydroxy-1-propyl)-hiyroximic acid-halogenid derivative, it's use for treating insulin resistance, and pharmaceutical compositions containing them as active component
NZ533795A (en) * 2002-01-11 2006-03-31 Biorex Kutato Fejlesztoe Kft Carboxamidine derivatives and their use in the treatment of vascular diseases
HUP0303584A3 (en) 2003-10-30 2009-12-28 Cytrx Corp Use of a hydroximic acid halide derivative in the treatment of neurodegenerative diseases
WO2008039514A1 (en) * 2006-09-26 2008-04-03 Cytrx Corporation Pharmaceutical compositions and methods for treating diseases associated with neurodegeneration
EP2089033A2 (en) * 2006-12-01 2009-08-19 CytRx Corporation Stroke recovery
TW200901958A (en) * 2007-05-04 2009-01-16 Cytrx Corp Diabetic wound healing
JP5429865B2 (ja) * 2009-09-15 2014-02-26 学校法人日本大学 生体外創傷治癒試験用用具または創傷作製方法
HUP1100535A2 (en) * 2011-09-26 2013-04-29 Bracelia Invest Ltd Pharmaceutical composition for enhancement of stem cell treatment
US9802927B2 (en) 2015-06-10 2017-10-31 Denali Therapeutics, Inc. Oxadiazine compounds and methods of use thereof
EP4247792A1 (en) 2020-11-19 2023-09-27 Zevra Denmark A/S Processes for preparing arimoclomol citrate and intermediates thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4187220A (en) * 1977-08-30 1980-02-05 Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara R.T. New O-(3-amino-2-hydroxy-propyl)-amidoxime derivatives, process for the preparation thereof and pharmaceutical compositions containing same
HU207988B (en) * 1988-10-20 1993-07-28 Biorex Kutato Fejlesztoe Kft Process for producing halogenides of o-/3-amino-2-hydroxy-propyl/hydroximic acid and pharmaceutical compositions containing them as active components
GB9017351D0 (en) * 1990-08-08 1990-09-19 Wellcome Found Medicaments for treatment of atherosclerosis
ES2123252T3 (es) * 1994-05-06 1999-01-01 Biorex Kutato Fejlesztoe Kft Nuevos derivados de acido hidroximico, composiciones farmaceuticas que los contienen y procedimiento para su preparacion.
HU218480B (hu) * 1995-06-15 2000-09-28 BIOREX Kutató és Fejlesztő Rt. Hidroxilaminszármazékok, eljárás előállításukra és a vegyületeket tartalmazó gyógyszerkészítmények
HU222994B1 (hu) * 1995-11-02 2004-01-28 BIOREX Kutató és Fejlesztő Rt. Hidroxilaminszármazékok és azok alkalmazása sejtek molekuláris chaperon-termelésének fokozására alkalmas gyógyszerkészítmények előállítására

Also Published As

Publication number Publication date
CA2262997A1 (en) 1998-02-19
BG103194A (bg) 1999-09-30
EP0966283B1 (en) 2006-06-14
BG64456B1 (bg) 2005-03-31
CA2262997C (en) 2008-07-29
NO990547D0 (no) 1999-02-05
EE9900044A (et) 1999-08-16
CZ298542B6 (cs) 2007-10-31
NO325109B1 (no) 2008-02-04
DE69736130T2 (de) 2007-01-04
AU3704997A (en) 1998-03-06
IL128256A0 (en) 2000-02-17
US6143741A (en) 2000-11-07
EP0966283A2 (en) 1999-12-29
NO990547L (no) 1999-03-25
RS49719B (sr) 2007-12-31
EE04044B1 (et) 2003-06-16
IL128256A (en) 2004-05-12
SK15499A3 (en) 2000-02-14
CZ43599A3 (cs) 1999-07-14
ATE329592T1 (de) 2006-07-15
SK284301B6 (sk) 2005-01-03
WO1998006400A3 (en) 1998-03-26
AU739614B2 (en) 2001-10-18
WO1998006400A2 (en) 1998-02-19
YU5199A (sh) 2000-10-30
DE69736130D1 (de) 2006-07-27
PT966283E (pt) 2006-08-31
JP2001504446A (ja) 2001-04-03
HK1025506A1 (en) 2000-11-17
UA64716C2 (en) 2004-03-15
ES2267148T3 (es) 2007-03-01

Similar Documents

Publication Publication Date Title
DK0750618T3 (da) Oxazolidinonderivater og farmaceutiske præparater indeholdende dem
NO20091159L (no) Hoyselektive reopptaksinhibitorer for norepinefrin
DE69725608D1 (de) Indolin-2-one derivate, verfahren zu ihrer herstellung und dieseenthaltende arzneimittel
ES2175127T3 (es) Derivados de la quinazolina y su uso.
NO20052739L (no) CCR5-antagonister som medikamenter
NO20025601D0 (no) Arylmetylaminderivater for anvendelse som tryptaseinhibitorer
HUP0101999A2 (hu) 4-Hidroxi-kinolin-3-karboxamid- és -hidrazid-származékok, ezeket tartalmazó gyógyászati készítmények, valamint e vegyületek alkalmazása
ES2164920T3 (es) Nuevos derivados heterociclicos y uso medicinal de los mismos.
DK0966283T3 (da) Farmaceutiske præparater til helbredelse og forebyggelse af sygdomme, som stammer fra beskadigelse af vaskulære endotelceller
NO922949L (no) Forbindelser og fremgangsmaater for inhibering av hiv- og beslektede virus
NL300202I1 (nl) Nucleotide-analogen.
DK0506539T3 (da) heterocykliske alkylamider, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som indeholder dem
EP0889041A4 (en) NEW IRIDOID DERIVATIVES AND NEOVASCULARIZATION INHIBITORS THAT CONTAIN THESE AS ACTIVE INGREDIENTS
DK1296972T3 (da) Arylmethylamin-derivater til anvendelse som tryptaseinhibitorer
DK0748314T3 (da) Tetrasubstituerede imidazolderivater, fremgangsmåde til deres fremstilling, deres anvendelse som lægemidler og farmaceutiske præparater med indhold deraf
NO995685D0 (no) Nye glycosylerte ginkgolidderivater, anvendelse derav som medikamenter og farmasöytiske blandinger
DK0866711T3 (da) Anvendelse af 6-methyl-5-oxo-3-thiomorpholinylcarbonyl-L-histidyl-L-prolinamid til fremstilling af et farmaceutisk præparat til modvirkning af sövnapnö
DK0678089T3 (da) N-Acylpyrrolidiner og lægemidler til behandling eller forebyggelse af cholecystokinin- og gastrin-relaterede forstyrrelser
ATE190845T1 (de) Rektale flunisolid-zubereitung zur behandlung entzündlicher darmerkrankungen
ATE228359T1 (de) Hemmung der leukotrienbiosynthese mittels harnstoffderivaten
DK1490049T3 (da) Citalopram til behandling af forhöjet blodtryk
PT971714E (pt) Metodo utilizando inibidores ciclooxigenase-2 no tratamento e prevencao da demencia
DK1263444T3 (da) Anvendelse af xanthinderivater til fremstilling af et lægemiddel, der er beregnet til forebyggelse eller behandling af osteoporose